Header Logo

Connection

Julie Schneider to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Julie Schneider has written about Antibodies, Monoclonal, Humanized.
Julie Schneider
Connection Strength
0.180
Antibodies, Monoclonal, Humanized
  1. Off-label use of aducanumab for cerebral amyloid angiopathy. Lancet Neurol. 2021 08; 20(8):596-597.
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.